"Esta es nuestra sede administrativa a nivel nacional donde puedes hacer tus trámites administrativos y de servicio al cliente. ¡Bienvenidos!"

During the past decade, Medplus Medicina Prepagada S.A. conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Medplus Medicina Prepagada S.A." are "Cardiovascular Disease" (2 trials), "Acute Respiratory Infection" (1 trials), "Crohn's Disease" (1 trials) and "Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the Protocol" (1 trials). Many other conditions were trialed in "Medplus Medicina Prepagada S.A." in a lesser frequency.

Most popular intervention types in "Medplus Medicina Prepagada S.A." are "Drug" (3 trials), "Biological" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "bococizumab (PF-04950615)" (2 trials), "Ad26.COV2.S" (1 trials), "Guselkumab" (1 trials) and "Guselkumab Dose 1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medplus Medicina Prepagada S.A." are 5 trials for "All" genders.

Currently, there are NaN active trials in "Medplus Medicina Prepagada S.A.". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Medplus Medicina Prepagada S.A., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Medplus Medicina Prepagada S.A., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".